BostonGene's immunoprofiling assay identifies hundreds of different cell types from a single tube of blood, providing a snapshot of the patient's immune health.
Immunoprofiling assays using flow cytometry are valuable tools for understanding the complex interactions between cancer cells and the immune system. This technique enables identification and characterization of immune and cancer cells in a patient’s blood sample, which can guide the development of personalized treatment plans.
- Identify surrogate biomarkers for clinical trial success
- Monitor disease progression and response to treatment
- Guide immunotherapy treatment
- Reveal a patient’s immune-related conditions